Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Relief Therapeutics Holding AG
  6. Summary
    RLF   CH0100191136

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
0.076(c) 0.0816(c) 0.0774(c) 0.0754(c) 0.0742(c) Last
11 859 292 26 943 756 5 493 695 9 350 573 8 047 557 Volume
-3.55% +7.37% -5.15% -2.58% -1.59% Change
More quotes
Estimated financial data (e)
Sales 2021 1,00 M 1,10 M 1,10 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 20,0 M 21,9 M 21,9 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 327 M 359 M 359 M
Capi. / Sales 2021 327x
Capi. / Sales 2022 16,4x
Nbr of Employees 10
Free-Float 66,2%
More Financials
Company
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The CompanyÔÇÖs objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either... 
More about the company
All news about RELIEF THERAPEUTICS HOLDING AG
01/19Relief Therapeutics Partner NRX Expands US Access to COVID-19 Treatment Zyesami
MT
01/19Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Ac..
EQ
01/14Relief Therapeutics Responds To NRx Lawsuit Claims; Shares Down 10%
MT
01/14Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Rec..
EQ
01/13GLOBAL MARKETS LIVE : Tesco, Google, Microsoft, Adler, TPG...
01/13NRX Pharmaceuticals Sues Relief Therapeutics for Alleged Breach of COVID-19 Drug Collab..
MT
01/12Relief Therapeutics Refutes NeuroRx's Breach of Contract, Defamation Claims
MT
01/12Relief Comments on Lawsuit Filed Against It by NeuroRx
EQ
01/06Relief Therapeutics Partner NRx Seeks US FDA's Emergency Use OK for COVID-19 Drug
MT
01/06Relief Reports US Collab. Partner announces Submission to FDA seeking EUA for Aviptadil..
EQ
01/05Relief Therapeutics to Participate in Virtual Investor Conferences in January
EQ
01/04Relief Therapeutics Partner NRX Seeks Provisional US Patent For Stable Compositions Of ..
MT
01/04Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provis..
EQ
01/03Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPE..
EQ
2021Relief Partner NRx Seeks US FDA's Breakthrough Therapy Tag for COVID-19 Drug
MT
More news
News in other languages on RELIEF THERAPEUTICS HOLDING AG
01/19Le partenaire de Relief Therapeutics, NRX, élargit l'accès au Zyesami, le traitement du..
01/18RELIEF : Nrx offre l'aviptadil aux patients Covid-19 à court d'options aux USA
01/14Relief-Partner NRx wehrt sich gegen Relief-Darstellungen in Rechtsstreit
01/14BOURSE ZURICH : dans le rouge pour la dernière séance de la semaine
01/14BOURSE ZURICH : accès de faiblesse du SMI en fin de semaine
More news
Chart RELIEF THERAPEUTICS HOLDING AG
Duration : Period :
Relief Therapeutics Holding AG Technical Analysis Chart | RLF | CH0100191136 | MarketScreener
Technical analysis trends RELIEF THERAPEUTICS HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,07 CHF
Average target price 0,52 CHF
Spread / Average Target 601%
Managers and Directors
Jack M. Weinstein Chief Financial Officer & Treasurer
Raghuram Selvaraju Chairman
Nermeen Varawalla Chief Medical Officer
Taneli Jouhikainen Chief Operating Officer
Thomas Plitz Director
Sector and Competitors
1st jan.Capi. (M$)
RELIEF THERAPEUTICS HOLDING AG19.29%359
MODERNA, INC.-36.98%64 900
LONZA GROUP AG-15.65%52 307
IQVIA HOLDINGS INC.-14.60%46 031
SEAGEN INC.-17.50%23 323
ICON PUBLIC LIMITED COMPANY-18.65%20 508